KH, H., S, D., S, S., A, L., S, R., P, R., . . . A, G. (2025). Personalized tobramycin dosing in children with cystic fibrosis: An AUC24-guided approach. Antimicrobial agents and chemotherapy, 69(9), e0027825. https://doi.org/10.1128/aac.00278-25
Chicago Style (17th ed.) CitationKH, Harwood, Duffull S, Shanthikumar S, Lei A, Ranganathan S, Robinson P, Sandaradura I, Lai T, and Gwee A. "Personalized Tobramycin Dosing in Children with Cystic Fibrosis: An AUC24-guided Approach." Antimicrobial Agents and Chemotherapy 69, no. 9 (2025): e0027825. https://doi.org/10.1128/aac.00278-25.
MLA (9th ed.) CitationKH, Harwood, et al. "Personalized Tobramycin Dosing in Children with Cystic Fibrosis: An AUC24-guided Approach." Antimicrobial Agents and Chemotherapy, vol. 69, no. 9, 2025, p. e0027825, https://doi.org/10.1128/aac.00278-25.